Search

Manufacture of cell-based health care products. Control of microbial risks during processing.

ISO 18362:2016/Amd 1:2022

Active

Manufacture of cell-based health care products — Control of microbial risks during processing — Amendment 1

Overview ISO 18362:2016/Amd 1:2022 is an important amendment to the international standard addressing the manufacture of cell-based health care products with a focus on the control of microbial risks…

ISO 18362:2016

Active

Manufacture of cell-based health care products — Control of microbial risks during processing

Overview ISO 18362:2016 - Manufacture of cell-based health care products - provides a risk-based framework for controlling viable and non‑viable microbial contamination during processing of cell‑base…